×

<- Back

Part 1 When Sepsis Really Takes Hold course

Speciality
Medical Doctors
Location
Online
Delivery
Online
Time / Duration
9 minutes
Subject matter expert
e-Learning for Healthcare
Provider
eIntegrity
Endorsed By
NHS, RCGP

Description:

This film concentrates on the case studies when they are in the acceleration phase of when sepsis takes control and when mild symtoms take on serious clinical features.

Programs this course belongs to
Modules this course belongs to
Type
Delivery
Title
Part 1 When Sepsis Really Takes Hold course
Location
Provider Type
Education Provider
Time / Duration
9 minutes
Location
Online
Posted By
eIntegrity Healthcare e-Learning
Access Duration (in months)
12
Price:
$19.00
Similar Listings
  • Anaesthesia | Pharmacology | Target controlled inf...
  • Posted By eIntegrity Healthcare e-Learning
  • Posted Date: 2026-07-18
  • Location:Online
  • This session will develop the three compartment model to include an effect-site and discuss its application to target-controlled infusions used for induction and maintenance of anaesthesia. The concept of context-sensitive half-time will be introduced.
  • Anaesthesia | Pharmacology | Clearance and volume ...
  • Posted By eIntegrity Healthcare e-Learning
  • Posted Date: 2026-07-18
  • Location:Online
  • This session will discuss clearance and volume of distribution and methods used to estimate and measure these kinetic parameters.
  • Anaesthesia | Pharmacology | Two- and three-compar...
  • Posted By eIntegrity Healthcare e-Learning
  • Posted Date: 2026-07-18
  • Location:Online
  • This session will develop pharmacokinetic modelling. The two- and three-compartment models will be introduced showing how the parameters described in a simple model are used in these more complicated models.
  • Anaesthesia | Pharmacology | Introduction to pharm...
  • Posted By eIntegrity Healthcare e-Learning
  • Posted Date: 2026-07-18
  • Location:Online
  • This session will introduce pharmacokinetics and modelling. The simple one-compartment model will be described and reasons presented as to why such a model rarely describes drug behaviour.
HealthcareLink